Cargando…
Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study
BACKGROUND: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients. METHODS: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and revie...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359920/ https://www.ncbi.nlm.nih.gov/pubmed/28320357 http://dx.doi.org/10.1186/s12883-017-0833-2 |
_version_ | 1782516485900468224 |
---|---|
author | Rollnik, J. D. Bertram, M. Bucka, C. Hartwich, M. Jöbges, M. Ketter, G. Leineweber, B. Mertl-Rötzer, M. Nowak, D. A. Platz, T. Scheidtmann, K. Thomas, R. von Rosen, F. Wallesch, C. W. Woldag, H. Peschel, P. Mehrholz, J. Pohl, M. |
author_facet | Rollnik, J. D. Bertram, M. Bucka, C. Hartwich, M. Jöbges, M. Ketter, G. Leineweber, B. Mertl-Rötzer, M. Nowak, D. A. Platz, T. Scheidtmann, K. Thomas, R. von Rosen, F. Wallesch, C. W. Woldag, H. Peschel, P. Mehrholz, J. Pohl, M. |
author_sort | Rollnik, J. D. |
collection | PubMed |
description | BACKGROUND: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients. METHODS: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and reviewed in respect to MDR status, length of stay (LOS) and the following outcome variables: Barthel Index (BI), Early Rehabilitation Index (ERI), Glasgow Outcome Score Extended (GOSE), Coma Remission Scale (CRS), Functional Ambulation Categories (FAC). RESULTS: The mean age of the study population was 68.0 ± 14.8 years. Upon admission, the following prevalence for MDRs was observed: MRSA (methicillin resistant staphylococcus aureus) 7.0% (53/754), ESBL- (extended spectrum beta-lactamase) producing bacteria strains 12.6% (95/754), VRE (vancomycin resistant enterococci) 2.8% (21/754). Patients colonized or infected with MDR bacteria (MDR+) were significantly more frequently diagnosed with a critical illness polyneuropathy – CIP – than non-colonized (MDR-) patients: 29.0% vs. 14.8%. In addition, they were more frequently mechanically ventilated (MDR+: 55/138, 39.9%; MDR- 137/616, 22.2%). MDR+ patients were referred to rehabilitation earlier, had a longer LOS in early rehabilitation, lower BI on admission and at discharge, lower ERI on admission and lower CRS at discharge than MDR- patients. There was a highly significant correlation of the BI upon admission with the BI at discharge (r(s) = 0.492, p < 0.001). GOSE at discharge differed significantly between both groups (χ (2)-test, p < 0.01). Perhaps of greatest importance, mortality among MDR+ was higher in comparison to MDR- (18.1% vs. 7.6%). CONCLUSIONS: The outcome of neurological early rehabilitation patients colonized or infected with MDR bacteria including MRSA or ESBL producing strains is significantly poorer than by non-colonized patients. There is some evidence that the poor outcome could be related to the higher morbidity and lower functional status upon admission. |
format | Online Article Text |
id | pubmed-5359920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53599202017-03-22 Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study Rollnik, J. D. Bertram, M. Bucka, C. Hartwich, M. Jöbges, M. Ketter, G. Leineweber, B. Mertl-Rötzer, M. Nowak, D. A. Platz, T. Scheidtmann, K. Thomas, R. von Rosen, F. Wallesch, C. W. Woldag, H. Peschel, P. Mehrholz, J. Pohl, M. BMC Neurol Research Article BACKGROUND: Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients. METHODS: In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and reviewed in respect to MDR status, length of stay (LOS) and the following outcome variables: Barthel Index (BI), Early Rehabilitation Index (ERI), Glasgow Outcome Score Extended (GOSE), Coma Remission Scale (CRS), Functional Ambulation Categories (FAC). RESULTS: The mean age of the study population was 68.0 ± 14.8 years. Upon admission, the following prevalence for MDRs was observed: MRSA (methicillin resistant staphylococcus aureus) 7.0% (53/754), ESBL- (extended spectrum beta-lactamase) producing bacteria strains 12.6% (95/754), VRE (vancomycin resistant enterococci) 2.8% (21/754). Patients colonized or infected with MDR bacteria (MDR+) were significantly more frequently diagnosed with a critical illness polyneuropathy – CIP – than non-colonized (MDR-) patients: 29.0% vs. 14.8%. In addition, they were more frequently mechanically ventilated (MDR+: 55/138, 39.9%; MDR- 137/616, 22.2%). MDR+ patients were referred to rehabilitation earlier, had a longer LOS in early rehabilitation, lower BI on admission and at discharge, lower ERI on admission and lower CRS at discharge than MDR- patients. There was a highly significant correlation of the BI upon admission with the BI at discharge (r(s) = 0.492, p < 0.001). GOSE at discharge differed significantly between both groups (χ (2)-test, p < 0.01). Perhaps of greatest importance, mortality among MDR+ was higher in comparison to MDR- (18.1% vs. 7.6%). CONCLUSIONS: The outcome of neurological early rehabilitation patients colonized or infected with MDR bacteria including MRSA or ESBL producing strains is significantly poorer than by non-colonized patients. There is some evidence that the poor outcome could be related to the higher morbidity and lower functional status upon admission. BioMed Central 2017-03-20 /pmc/articles/PMC5359920/ /pubmed/28320357 http://dx.doi.org/10.1186/s12883-017-0833-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Rollnik, J. D. Bertram, M. Bucka, C. Hartwich, M. Jöbges, M. Ketter, G. Leineweber, B. Mertl-Rötzer, M. Nowak, D. A. Platz, T. Scheidtmann, K. Thomas, R. von Rosen, F. Wallesch, C. W. Woldag, H. Peschel, P. Mehrholz, J. Pohl, M. Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study |
title | Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study |
title_full | Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study |
title_fullStr | Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study |
title_full_unstemmed | Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study |
title_short | Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study |
title_sort | outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a german multi-center study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359920/ https://www.ncbi.nlm.nih.gov/pubmed/28320357 http://dx.doi.org/10.1186/s12883-017-0833-2 |
work_keys_str_mv | AT rollnikjd outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT bertramm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT buckac outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT hartwichm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT jobgesm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT ketterg outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT leineweberb outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT mertlrotzerm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT nowakda outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT platzt outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT scheidtmannk outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT thomasr outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT vonrosenf outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT walleschcw outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT woldagh outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT peschelp outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT mehrholzj outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy AT pohlm outcomeofneurologicalearlyrehabilitationpatientscarryingmultidrugresistantbacteriaresultsfromagermanmulticenterstudy |